On this page
Buprenorphine
Active ingredient 7 prescription 30 with labelling
Overview
Source: NDC DirectoryIngredient name
BUPRENORPHINE
Base moiety
BUPRENORPHINE
RxNorm CUI
UNII
40D3SCR4GZ
Medication products
9
Brand names
6
Dosage forms
6
FAERS reports
124,274 · not a risk measure
- Buprenorphine Powder
- Buprenorphine Base Powder
- BRIXADI Buprenorphine · Injection
- Buprenorphine Patch, Extended Release
- Buprenorphine Patch
- Buprenorphine and Naloxone Tablet
- buprenorphine transdermal system buprenorphine · Patch, Extended Release
- Butrans buprenorphine · Patch, Extended Release
- SUBLOCADE buprenorphine · Solution
Entries without a link are products listed by the FDA that carry no approval record, therapeutic equivalence rating or official labelling, so they have no detail page. Their facts are shown inline.
By dosage form
| Dosage form | Products | Examples |
|---|---|---|
| PATCH, Extended Release | 3 | Buprenorphine, buprenorphine transdermal system, Butrans |
| Powder | 2 | Buprenorphine, Buprenorphine Base |
| Injection | 1 | BRIXADI |
| Patch | 1 | Buprenorphine |
| Tablet | 1 | Buprenorphine and Naloxone |
| Solution | 1 | SUBLOCADE |
Sources for this page
| Dataset | Agency | Used for |
|---|---|---|
| NDC Directory | FDA | Ingredient name, strengths, products, labelers, packages |
| DailyMed RxNorm mappings | NLM | RxNorm concept identifier (RxCUI) |
| FAERS | FDA | Adverse event report totals |